Total marrow irradiation (TMI) with PET-guided 'boosts' as a personalized conditioning regimen for the first of tandem autologous HSCT in multiple myeloma. Interim analysis of a phase II clinical trial

被引：0
|
作者：
Giebel, S. [1 ]
Najda, J. [1 ]
Kruzel, T. [1 ]
Sadus-Wojciechowska, M. [1 ]
Czerw, T. [1 ]
Jochymek, B. [1 ]
Glowacki, G. [1 ]
Matulewicz, L. [1 ]
Holowiecki, J. [1 ]
Bobek-Billewicz, B. [1 ]
Slosarek, K. [1 ]
Miszczyk, L. [1 ]
机构：
[1] M Sklodowska Curie Mem Inst, Gliwice Branch, Gliwice, Poland
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S222 / S223
页数：2
相关论文
共 11 条
  • [1] TANDEM AUTOHSCT WITH SEQUENTIAL USE OF TOTAL MARROW IRRADIATION AND HIGH-DOSE MELPHALAN IN MULTIPLE MYELOMA. INTERIM ANALYSIS OF A PHASE II CLINICAL TRIAL
    Giebel, S.
    Kruzel, T.
    Sadus-Wojciechowska, M.
    Najda, J.
    Czerw, T.
    Mendrek, W.
    Blamek, S.
    Glowacki, G.
    Jochymek, B.
    Matulewicz, L.
    Radwan, M.
    Leszczynski, W.
    Dolla, L.
    D'Amico, A.
    Slosarek, K.
    Holowiecki, J.
    Miszczyk, L.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S74 - S74
  • [2] Total Marrow Irradiation (TMI): A New Ablative Regimen as Part of Tandem (T) Autologous Peripheral Blood Progenitor Cell Transplant (AT) for Patients (pts) with Multiple Myeloma (MM)
    Somlo, George
    Spielberger, Ricardo
    Frankel, Paul
    Karanes, Chatchada
    Krishnan, Arnrita
    Parker, Pablo Miguel
    Popplewell, Leslie
    Sahebi, Firoozeh
    Schultheiss, Tim
    Kogut, Neil Martin
    Liu, An
    Snyder, David S.
    Forman, Stephen J.
    Wong, Jeffrey Y.
    BLOOD, 2008, 112 (11) : 1142 - 1143
  • [3] Total marrow irradiation (TMI) combined with treosulfan and fludarabine conditioning regimen for chemosensitive advanced multiple myeloma (MM) patients undergoing matched allogeneic stem-cell transplantation: First results of a phase I/II prospective monocentric study (TrRaMM TMI).
    Assanelli, Andrea A.
    Lorentino, Francesca
    Marcatti, Magda
    Chiara, Anna
    Teresa, Maria
    Stanghellini, Lupo
    Giglio, Fabio
    Clerici, Daniela
    Greco, Raffaella
    Broggi, Sara
    Cattaneo, Mauro
    Peccatori, Jacopo
    Ferreri, Andres J.
    Ciceri, Fabio
    Di Muzio, Nadia
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Phase I/II trial of total marrow irradiation, busulfan and cyclophosphamide followed by peripheral autologous PBSCT in patients with advanced multiple myeloma
    Einsele, H
    Bamberg, M
    Budach, H
    Schmidt, H
    Hebart, H
    Trumper, L
    Loffler, B
    Hoffmann, A
    Schlimok, G
    Hertenstein, B
    Peest, D
    Ganser, A
    Metzner, B
    Frickhofen, N
    Faul, C
    Brugger, W
    Kanz, L
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 427 - 427
  • [5] Addition of Myeloablative Doses of Total Marrow Irradiation (TMI) to Myeloablative Fludarabine/Busulfan Conditioning for Allogeneic HSCT in Patients with High-Risk AML, CML, or Myelodysplastic Syndrome: A Phase II Clinical Trial
    Maahs, Lucas
    Koshy, Matthew
    Sweiss, Karen
    Ahn, Kang-Hyun
    Chen, Zhengjia
    Uzoka, Chukwuemeka
    Galvez, Carlos
    Rubinstein, Paul
    Quigley, John
    Saraf, Santosh L.
    Rodriguez, Ana Maria Avila
    Aydogan, Bulent
    Mahmud, Nadim
    Rondelli, Damiano
    BLOOD, 2023, 142
  • [6] A phase I/II trial of total marrow irradiation, busulfan and cyclophosphamide followed by peripheral blood stem cell transplantation in patients with advanced multiple myeloma.
    Einsele, H
    Bamberg, M
    Schmidberger, H
    Schmidt, H
    Hebart, H
    Faul, C
    Weiss, B
    Brugger, W
    Kanz, L
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 707 - 707
  • [7] Total marrow irradiation (TMI) with helical tomotherapy and peripheral blood progenitor cell rescue (PBPC) following high-dose melphalan (Mel) and PBPC as part of tandem autologous transplant (TAT) for patients with multiple myeloma.
    Somlo, George
    Liu, An
    Schultheiss, Timothy E.
    Frankel, Paul Henry
    Spielberger, Ricardo Tomas
    Popplewell, Leslie
    Zhou, Kenny
    Hawkins, Donna
    Krishnan, Amrita Y.
    Sahebi, Firoozeh
    Parker, Pablo Miguel
    Forman, Stephen J.
    Wong, Jeffrey Y. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [8] A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200mg/m2 and total marrow irradiation (TMI) in patients with relapsed/refractory multiple myeloma
    Patel, Pritesh
    Oh, Annie L.
    Koshy, Matthew
    Sweiss, Karen
    Saraf, Santosh L.
    Quigley, John G.
    Khan, Irum
    Mahmud, Nadim
    Hacker, Eileen
    Ozer, Howard
    Peace, David J.
    Weichselbaum, Ralph R.
    Aydogan, Bulent
    Rondelli, Damiano
    LEUKEMIA & LYMPHOMA, 2018, 59 (07) : 1666 - 1671
  • [9] Escalated Dose-Rates of Total Marrow Irradiation (TMI) Combined with Treosulfan and Fludarabine-Based Conditioning Chemotherapy Regimen for Chemosensitive Advanced Multiple Myeloma (MM) Patients Undergoing a Matched Allogeneic Stem-Cell Transplantation: First Results of a Phase I/II Prospective Monocentric Study (TrRaMM TMI)
    Assanelli, Andrea Angelo
    Lorentino, Francesca
    Marcatti, Magda
    Chiara, Anna
    Perini, Tommaso
    Stanghellini, Maria Teresa Lupo
    Giglio, Fabio
    Morelli, Mara
    Greco, Raffaella
    Broggi, Sara
    Cattaneo, Mauro
    Peccatori, Jacopo
    Bonini, Chiara
    Di Muzio, Nadia
    Ciceri, Fabio
    BLOOD, 2016, 128 (22)
  • [10] Phase I trial of escalating doses of total marrow irradiation (TMI) with helical tomotherapy and peripheral blood progenitor cell rescue (PBPC), following high-dose melphalan and PBPC as part of tandem high-dose therapy (THDT) for patients with multiple myeloma (MM)
    Somlo, G.
    Forman, S.
    Popplewell, L.
    Parker, P.
    Schultheiss, T.
    Wong, J.
    Frankel, P.
    Spielberger, R.
    Sahebi, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 193 - 193
12